BUSINESS
India is making its mark in clinical trials amid changing global landscape
Clinical trial activity has increased in India
BUSINESS
Moneycontrol Pro Panorama | Metals on a roll, how should you invest?
In this Moneycontrol Pro Panorama edition: IMF data contradicts prevailing global slowdown narrative, markets debate whether Nifty has peaked twice, India’s healthcare demand far outpaces system capacity, and more
BUSINESS
Budget Snapshot: The wide gap between India’s healthcare needs and delivery capacity
A large number of hospital beds are currently concentrated in urban areas
BUSINESS
China will raise competition for BHEL, but unlikely to hurt its business significantly
Investors would do well to focus on execution of order backlog at BHEL
BUSINESS
State policy changes inducing growth headwinds for alcoholic beverage companies
Large companies are estimated to report subdued revenue growth rates in December quarter
BUSINESS
El Nino will raise electricity demand, but can hurt farm sector
El Nino conditions can pose growth challenges for agrochemicals industry for the second consecutive year
BUSINESS
Moneycontrol Pro Panorama | A steady start to Q3 earnings season
For January 6 edition of Moneycontrol Pro Panorama: Venezuela’s impact remains an untold story, subsidy rises due to high prices and limited supply, India must address urban waste issues urgently, and more
BUSINESS
Budget Snapshot: Fertiliser subsidy to rise on firm prices, tight supplies
In India, government provides subsidy to manufacturers for selling fertilisers below the production cost
BUSINESS
Indian IT should strike a fine balance as AI investments take off
IT companies are making large acquisitions and also investing in new technologies
BUSINESS
Tough adjustments await the green energy sector in 2026
Plain vanilla solar power is no longer in demand
BUSINESS
Moneycontrol Pro Panorama | The changing pecking order in India’s passenger vehicle market
In this December 30 edition of Moneycontrol Pro Panorama: Natural gas prices may enter a prolonged super-cycle, weight-loss drugs expected to boost Indian pharma, emerging AI trends set to shape India’s ecosystem, and more
BUSINESS
Chart of the Day: Weight loss drugs to give fillip to Indian pharma market in 2026
Generic weight loss drugs can help expand Indian pharma market
BUSINESS
Power sector’s growth tempo broke in 2025, will it revive in 2026?
Demand slowdown weighed on earnings of electricity producers
BUSINESS
Moneycontrol Pro Panorama | The making of pan-India hospital chains
For Moneycontrol's Pro Panorama December 23 edition: India-New Zealand FTA matters more than critics suggest, from stabilisation to growth in India's 2026 equity market, China’s export pivot creates new risks, bond market outlook in 2026, and more
BUSINESS
Chart of the Day: Defence contract awards to exceed Rs 2 lakh crore for the second straight year
The government is likely to award contracts for at least Rs 10 lakh crore worth of defence equipment in the next five years
BUSINESS
Moneycontrol Pro Panorama | Good tidings for Indian IT from Accenture's results
For Moneycontrol's Pro Panorama December 19 edition: Growth strong but jobs lag behind, a look at India’s coal growth story, what’s holding the market back? and more
BUSINESS
Chart of the Day: India to be the last major growing market for coal
Coal demand and production in India are expected to grow faster than major countries
BUSINESS
Anupam Rasayan makes an opportune bet on Jayhawk in the US
The acquisition will improve Anupam’s revenue mix and add new products
BUSINESS
CoalSETU to drive optimal utilisation of coal reserves
Removal of end-use restrictions will help expand potential market for domestic coal and substitute imports, amid moderating demand for coal
BUSINESS
Data Story: Private sector is tightening its grip over India’s healthcare services market
The hospitals and clinics market is estimated to exceed Rs 10 lakh crore by FY29
BUSINESS
Moneycontrol Pro Panorama | A year-end peek into business strategies
In Moneycontrol's Pro Panorama December 9 edition: Indian pharma growth momentum continues, US pivot a signal for Asia to hedge, GDP deflation impact explained, India enters a new era of food preferences, and more
BUSINESS
Chart of the Day: New products, price hikes keep up the growth momentum for Indian pharma
Among large companies, Sun Pharma and Cipla gained market share in the last 12 months
BUSINESS
Moneycontrol Pro Panorama | Gold dust on online marketplaces, but will everyone get rich?
Moneycontrol Pro Panorama December 4 edition: India is positioning itself strategically in rare earths, rupee weakness boosts IT competitiveness, Japan’s bond market risks rise, India's market outperforms despite global AI surge, and more
BUSINESS
Chart of the Day: Rupee depreciation to bring relief for Indian IT
While IT companies derive most of their revenues from overseas, a large portion of their expenditure is incurred in local currency
